Clinical Trials Browser

Terminated × Prostatic Neoplasms × Ascorbic Acid × Clear all

NCT05501548 2025-01-29

Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer

Phase 2 Terminated

4 enrolled 5 charts

Prostatic Neoplasms

NCT02516670 2023-06-07

Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate Cancer

Phase 2 Terminated

50 enrolled 15 charts

Prostatic Neoplasms